Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its wholly owned subsidiary, MindWave Innovations Inc., has signed a 12-month software development and technology services agreement with Flash Sports & Media Holdings, Inc. to build and operate FlashChain, a blockchain designed to track digital broadcasting rights, video assets and match ticket inventory.
Under the agreement, MindWave will deploy a dedicated FlashChain subnet on its MindChain Layer-2 infrastructure, operate validator nodes and develop software connecting Flash streaming and ticketing platforms and gate-scanning hardware to the network. MindWave will also develop smart contracts to authenticate digital match tickets, manage digital sports memorabilia and help prevent ticket counterfeiting and unauthorized duplication of media.
In return, MindWave will receive Flash Sports & Media Holdings common shares and an allocation equal to 20% of the total supply of FLASH TOKEN, along with an annual maintenance fee equal to 50% of applicable contract consideration. The parties have not publicly disclosed the aggregate dollar value of the agreement. To view the full press release, visit https://ibn.fm/LD2UM.
MindChain is a blockchain infrastructure developed within the MindWave ecosystem to support transparent, traceable and verifiable digital transactions. It is designed to provide the underlying ledger capabilities required for applications involving digital assets, registries, tokenized ecosystems and decentralized services. FlashChain will run as a dedicated, independently branded subnet on MindChain’s Layer-2 infrastructure and may participate in MindChain’s insurance program, subject to its coverage terms.
MindWave Innovations Inc., a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc., is developing enterprise blockchain infrastructure and institutional technology platforms through its MindChain ecosystem. Four ecosystems operate under MindChain: InsurTech through BlockAssure, which is developing a Bermuda-framework platform applying Bitcoin reserves as regulatory capital to support life and property and casualty underwriting; ClimateTech through AQUAE and the ALCI index, measuring, verifying and tokenizing ecosystem services into institutional-grade assets; HealthTech through the Apitox development program; and RWA Tech through Nexus Global Partners, bringing institutional real estate on-chain within a compliance-first, insurance-enhanced framework.
The latest news and updates relating to APUS are available in the company’s newsroom at https://ibn.fm/APUS. The announcement was distributed through TechMediaWire, a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach target markets, demographics and industries, as well as article and editorial syndication to 5,000+ outlets.
For investors, the agreement signals MindWave’s push to commercialize its MindChain infrastructure in the sports and media sector, potentially opening new revenue streams tied to digital rights management and ticketing. For the broader sports industry, FlashChain could offer a scalable solution to combat ticket fraud and unauthorized media distribution, a persistent challenge for leagues and broadcasters. The deal also underscores the growing trend of blockchain adoption in entertainment and media, where transparency and traceability are increasingly valued. However, the undisclosed contract value and the early-stage nature of the technology mean the financial impact for Apimeds remains uncertain. The company’s shares trade on the NYSE American under the ticker APUS.
